{"id":"https://openalex.org/W2943546226","doi":"https://doi.org/10.1111/dom.13764","title":"Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo\u2010controlled trial in patients with type 2 diabetes using metformin","display_name":"Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo\u2010controlled trial in patients with type 2 diabetes using metformin","alternate_titles":[],"publication_year":2019,"publication_date":"2019-05-03","ids":{"openalex":"https://openalex.org/W2943546226","doi":"https://doi.org/10.1111/dom.13764","mag":"2943546226","pmid":"https://pubmed.ncbi.nlm.nih.gov/31050143"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13764","doi":"https://doi.org/10.1111/dom.13764","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.13764","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2943546226"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086072427","display_name":"Juan P. Fr\u00edas","orcid":"https://orcid.org/0000-0001-9486-1255","observed_orcids":["https://orcid.org/0000-0001-9486-1255"]},"institutions":[{"id":"https://openalex.org/I4210111119","display_name":"National Research Institute","ror":"https://ror.org/02201aj62","country_code":"US","type":"other","lineage":["https://openalex.org/I4210111119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan P. Frias","raw_affiliation_strings":["National Research Institute, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-9486-1255","affiliations":[{"raw_affiliation_string":"National Research Institute, Los Angeles, California","institution_ids":["https://openalex.org/I4210111119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051782505","display_name":"Alan G Wynne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan G. Wynne","raw_affiliation_strings":["Cotton O'Neil Diabetes and Endocrinology Center, Topeka, Kansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cotton O'Neil Diabetes and Endocrinology Center, Topeka, Kansas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088849037","display_name":"Beata Matyjaszek\u2010Matuszek","orcid":"https://orcid.org/0000-0001-7386-8087","observed_orcids":["https://orcid.org/0000-0001-7386-8087"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Beata Matyjaszek\u2010Matuszek","raw_affiliation_strings":["Department of Endocrinology, Medical University of Lublin, Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Medical University of Lublin, Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030573958","display_name":"Dagmar Bart\u00e1\u0161kov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dagmar Bartaskova","raw_affiliation_strings":["Diabetologick\u00e1 Ambulance  Prague Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetologick\u00e1 Ambulance  Prague Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Cox","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057872199","display_name":"Brad Woodward","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad Woodward","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003331531","display_name":"Ying Grace Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying G. Li","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022862627","display_name":"Lai San Tham","orcid":"https://orcid.org/0000-0002-1249-8526","observed_orcids":["https://orcid.org/0000-0002-1249-8526"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lai S. Tham","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024563374","display_name":"Zvonko Mili\u010devi\u0107","orcid":"https://orcid.org/0000-0002-6746-901X","observed_orcids":["https://orcid.org/0000-0002-6746-901X","https://orcid.org/0009-0002-8641-023X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zvonko Milicevic","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":"https://orcid.org/0000-0002-6746-901X","affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024563374"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.0977,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.91068039,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"9","first_page":"2048","last_page":"2057"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9440000057220459},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9089999794960022},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7319999933242798},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7509999871253967},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8190000057220459},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9700000286102295},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8619999885559082},{"id":"https://openalex.org/keywords/fasting-serum-glucose","display_name":"fasting serum glucose","score":0.9729999899864197},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5789999961853027},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6980000138282776},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.6399999856948853},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.45899999141693115},{"id":"https://openalex.org/keywords/dizziness","display_name":"dizziness","score":0.375},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.9915981292724609},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8553148508071899},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8190101385116577},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6008904576301575},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5639762878417969},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4912068247795105},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43245238065719604},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3582412302494049},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35502880811691284},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2955056428909302},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.27181822061538696},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.13764","doi":"https://doi.org/10.1111/dom.13764","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.13764","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:31050143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31050143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W906438903","https://openalex.org/W1578533615","https://openalex.org/W1992055007","https://openalex.org/W2002757015","https://openalex.org/W2003589032","https://openalex.org/W2030546890","https://openalex.org/W2054981500","https://openalex.org/W2090054860","https://openalex.org/W2097771449","https://openalex.org/W2104252114","https://openalex.org/W2109416725","https://openalex.org/W2117764934","https://openalex.org/W2160088494","https://openalex.org/W2165556241","https://openalex.org/W2172193326","https://openalex.org/W2282876332","https://openalex.org/W2414005931","https://openalex.org/W2443999297","https://openalex.org/W2610752282","https://openalex.org/W2611275678","https://openalex.org/W2695892839","https://openalex.org/W2746874591"],"related_works":["https://openalex.org/W2809038136","https://openalex.org/W3119307884","https://openalex.org/W3021170016","https://openalex.org/W2030546890","https://openalex.org/W906438903","https://openalex.org/W3035308344","https://openalex.org/W1562038277","https://openalex.org/W2261901121"],"abstract_inverted_index":{"AIMS:":[0],"Dulaglutide,":[1],"a":[2,386],"once":[3],"weekly":[4],"GLP-1":[5],"receptor":[6],"agonist,":[7],"is":[8],"approved":[9],"at":[10,115,138,159],"two":[11],"doses":[12,26,43,108,142,252,307,333,355],"(1.5":[13,258],"and":[14,30,37,52,133,324,342,360,368],"0.75":[15],"mg)":[16,32],"for":[17,35,47,315,327,354],"treatment":[18],"of":[19,27,50,77,106,113,122,143,304,356,358],"type":[20],"2":[21,62],"diabetes":[22],"(T2D).":[23],"Two":[24],"higher":[25,306],"dulaglutide":[28,82,88,95,107,123,144,166,177,187,197,223,230,237,251,332,357],"(3.0":[29],"4.5":[31,96,198,238,272,278,292,361],"were":[33,145,213,308,319,334],"evaluated":[34],"safety":[36,313,374],"efficacy":[38],"to":[39,73,147,322,336,363],"determine":[40],"whether":[41],"these":[42],"warrant":[44],"further":[45,383],"study":[46,384],"improved":[48],"control":[49,341],"glucose":[51,136],"body":[53,131,216,344],"weight.":[54],"MATERIALS":[55],"AND":[56],"METHODS:":[57],"This":[58],"18-week,":[59],"double-blind,":[60],"phase":[61,387],"trial":[63],"randomized":[64],"318":[65],"patients":[66],"with":[67,165,310,348,371,377],"T2D":[68,349],"using":[69,350],"\u22651500":[70],"mg":[71,84,90,97,150,362,380],"metformin,":[72],"receive":[74],"subcutaneous":[75],"injection":[76],"placebo":[78,110,125,168,289,337],"(n":[79,85,91,98],"=":[80,86,92,99],"82),":[81],"1.5":[83,149,178,224,379],"81),":[87],"3.0":[89,188,231,268,359],"79)":[93],"or":[94],"76).":[100],"The":[101,352],"primary":[102],"objective":[103],"was":[104,162,325],"superiority":[105,121],"over":[109,124],"in":[111,126,130,215,338,346,385],"reduction":[112,158,370],"HbA1c":[114,157],"18":[116,139,160],"weeks.":[117,140],"Secondary":[118],"objectives":[119],"included":[120],"change":[127],"from":[128,256],"baseline":[129,257],"weight":[132,217,345,369],"fasting":[134],"serum":[135],"(FSG)":[137],"Investigational":[141],"compared":[146,376],"the":[148,305,311,378],"dose":[151],"as":[152,212],"an":[153,372],"exploratory":[154],"objective.":[155],"RESULTS:":[156],"weeks":[161],"significantly":[163,253],"greater":[164],"vs":[167,288],"(placebo,":[169,218],"-0.44%":[170],"\u00b1":[171,174,181,184,191,194,201,204,220,227,234,241,261,265,271,275,281,285,291,295],"0.10%":[172,182,192,202],"[-4.8":[173],"1.1":[175,185,195,205],"mmol/mol];":[176,186,196,206],"mg,":[179,189,199,225,232,239,259,269,279],"-1.23%":[180],"[-13.5":[183],"-1.31%":[190],"[-14.3":[193],"-1.40%":[200],"[-15.3":[203],"P":[207,244],"<":[208,245,299],"0.001,":[209,246,300],"each":[210,247],"dose),":[211],"changes":[214],"-1.6":[219],"0.39":[221,228,235],"kg;":[222,229,236,243],"-2.8":[226],"-3.9":[233],"-4.1":[240],"0.41":[242],"dose).":[248],"All":[249,330],"three":[250,331],"reduced":[254],"FSG":[255],"-36.2":[260],"4.7":[262,282],"mg/dL":[263,273,283,293],"[-2.0":[264],"0.3":[266,276,286,296],"mmol/L];":[267,277],"-34.5":[270],"[-1.9":[274],"-38.0":[280],"[-2.1":[284],"mmol/L])":[287,297],"(-12.4":[290],"[-0.7":[294],"(P":[298],"all).":[301],"Safety":[302],"profiles":[303],"consistent":[309],"established":[312],"profile":[314],"dulaglutide.":[316],"Gastrointestinal":[317],"events":[318],"mostly":[320],"mild":[321],"moderate,":[323],"dose-related":[326],"nausea.":[328],"CONCLUSION:":[329],"superior":[335],"improving":[339],"glycaemic":[340,366],"reducing":[343],"participants":[347],"metformin.":[351],"potential":[353],"provide":[364],"additional":[365],"benefit":[367],"acceptable":[373],"profile,":[375],"dose,":[381],"warrants":[382],"3":[388],"trial.":[389]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2943546226","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-05-09T00:00:00"}
